COVID‐19‐Associated Critical Illness Myopathy with Direct Viral Effects

Coronavirus disease 2019 (COVID‐19) severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2 infection) can lead to intensive care unit (ICU) admission and critical illness myopathy (CIM). We examined 3 ICU patients with COVID‐19 who required mechanical ventilation for pneumonia and developed CIM. Pathological examination of the skeletal muscle biopsies revealed myopathic changes consistent with CIM, variable inflammation with autophagic vacuoles, SARS‐CoV immunostaining + fibers/granules, and electron microscopy findings of mitochondrial abnormalities and coronavirus‐like particles. Although mitochondrial dysfunction with compromised energy production is a critical pathogenic mechanism of non‐COVID‐19‐associated CIM, in our series of COVID‐19‐associated CIM, myopathic changes including prominent mitochondrial damage suggest a similar mechanism and association with direct SARS‐CoV‐2 muscle infection. ANN NEUROL 2022;91:568–574

• Publication year

  2022

• Venue

  Annals of Neurology

• Publication date

  2022-02-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ana.26318PMID 35148013PMCID 9082461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

  2023influential reference
• RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

  2021cited by this paper
• Myopathic changes in patients with long-term fatigue after COVID-19

  2021cited by this paper
• Post-COVID-19 acute sarcopenia: physiopathology and management

  2021cited by this paper
• Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study

  2021cited by this paper
• COVID-19 IgG-related autoimmune inflammatory necrotizing myositis

  2021cited by this paper
• Critical illness myopathy and polyneuropathy in Covid-19: Is it a distinct entity?

  2021cited by this paper
• Neuromuscular complications of coronavirus disease-19

  2021cited by this paper
• Skeletal Muscle and Peripheral Nerve Histopathology in COVID-19

  2021cited by this paper
• Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died.

  2021cited by this paper
• Neuromuscular involvement in COVID-19 critically ill patients

  2020influential reference
• Reconsidering critical illness as an uncharacterised acquired mitochondrial disorder

  2020cited by this paper
• Increased intra-mitochondrial lipofuscin aggregates with spherical dense body formation in mitochondrial myopathy.

  2020cited by this paper
• Intensive Care Unit-Acquired Weakness: Neuropathology.

  2020cited by this paper
• Critical Illness Myopathy.

  2020cited by this paper
• Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction

  2020cited by this paper
• Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities

  2020cited by this paper
• Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

  2020cited by this paper
• The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

  2015cited by this paper
• Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies

  2013cited by this paper
• Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis.

  2011cited by this paper
• Association between mitochondrial dysfunction and severity and outcome of septic shock.

  2002cited by this paper
• Critical illness myopathy

  2001cited by this paper
• Muscle Biopsy. A Practical Approach

  1986cited by this paper

• Muscle disease in severe COVID-19 patients: a microangiopathic myopathy

  2025cites this paper
• Neurophysiology and muscle histopathology in ICU-acquired muscle weakness: Lessons learned from COVID-19

  2025influential citation
• The protein interaction of mitochondrial transcription factors A and B2 is associated with 30-day survival in critical COVID-19

  2025cites this paper
• Characterization of SARS‐CoV‐2 Entry Genes in Skeletal Muscle and Impacts of In Vitro Versus In Vivo Infection

  2025influential citation
• Prognostic significance of muscle fasciculations in critically Ill COVID-19 patients under mechanical ventilation

  2024cites this paper
• Neurological complications caused by SARS-CoV-2

  2024cites this paper
• Persistent Fatigue, Weakness, and Aberrant Muscle Mitochondria in Survivors of Critical COVID-19

  2024cites this paper
• New Insights into the Effects of SARS-CoV-2 on Metabolic Organs: A Narrative Review of COVID-19 Induced Diabetes

  2024cites this paper
• Neuromuscular problems of the critically Ill neonate and child.

  2024cites this paper
• Secondary mitochondrial dysfunction across the spectrum of hereditary and acquired muscle disorders.

  2024cites this paper
• Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies

  2023cites this paper
• Comparison of plasma mitochondrial DNA copy number in asymptomatic and symptomatic COVID-19 patients

  2023cites this paper
• Recovery of neurophysiological measures in post-COVID fatigue: a 12-month longitudinal follow-up study

  2023cites this paper
• Neuromuscular Complications of COVID-19: Evidence from the Third Year of the Global Pandemic

  2023cites this paper
• Neurorecovery after Critical COVID-19 Illness

  2023cites this paper
• Mitochondrial Dysfunction in Intensive Care Unit-Acquired Weakness and Critical Illness Myopathy: A Narrative Review

  2023cites this paper
• Continued False‐Positive Detection of SARS‐CoV‐2 by Electron Microscopy

  2022cites this paper
• Deep Brain Stimulation for Tremor: Direct Targeting of a Novel Imaging Biomarker

  2022cites this paper
• Muscle biopsy in myositis: What the rheumatologist needs to know.

  2022cites this paper
• Imaging Techniques: Essential Tools for the Study of SARS-CoV-2 Infection

  2022cites this paper
• COVID-19 associated myopathy.

  2022cites this paper
• What Is in the Myopathy Literature?

  2022cites this paper
• Neuromuscular disease: 2022 update.

  2022cites this paper
• Prognostic signi fi cance of muscle fasciculations in critically Ill COVID-19 patients under mechanical ventilation

  year unknowncites this paper